FLT1 and cancer: While a previous study showed evidence that intact VEGF-VEGFR signaling is necessary for the successful effects of anti-VEGF/VEGFR drugs, [4] the study was conducted using cancer cells that originated from various human tissues, and the individual roles of FLT1 or KDR epigenetic gene silencing were not appropriately evaluated.